Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil;Disseminação Intrahospitalar de Pseudomonas aeruginosa em Hospital Universitário de Florianópolis, Santa Catarina, Brasil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 4, 2010, Pages 367-371

  Scheffer, Mara Cristina ^a,c   Bazzo, Maria Luiza ^a   Steindel, Mario ^a   Darini, Ana Lucia ^b   Clímaco, Eduardo ^b   Dalla Costa, Libera Maria ^c,d  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d Research Institute Pelé Pequeno Príncipe   (Brazil)

Author keywords

Carbapenem resistance; Nosocomial infections; Pseudomonas aeruginosa

Indexed keywords

AZTREONAM; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B;

ACINETOBACTER BAUMANNII; AGAR DILUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; UNIVERSITY HOSPITAL;

PSEUDOMONAS AERUGINOSA;

EID: 77957978259     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000400006     Document Type: Article

References (30)

1. Sader HS, Gales AC, Pfaller MA, Mendes RE, Zoccoli C, Barth A, et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001; 5:200-214.
2. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005; 4(suppl 11):17-32.
3. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634-640.
4. Cezario RC, Duarte De Morais L, Ferreira JC, Costa-Pinto RM, da Costa Darini AL, Gontijo-Filho PP. Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin 2009; 27:269-274.
5. Zavascki AP, Gaspareto PB, Martins AF, Goncalves AL, Barth AL. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 2005; 56:1148-1151.
6. Furtado GH, Bergamasco MD, Menezes FG, Marques D, Silva A, Perdiz LB, et al. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: Risk factors and mortality. J Crit Care 2009; 24:625.e9-14.
7. Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, et al. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 2006; 58:387-392.
8. Ribeiro J, Mendes RE, Domingos R, Franca E, Silbert S, Jones RN, et al. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program. J Chemother 2006; 18:461-467.
9. Gales AC, Menezes LC, Silbert S, Sader HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J Antimicrob Chemother 2003; 52:699-702.
10. York MK, Schreckenberger PC, Miller JM. Identification of Gram-negative bacteria. In: Isenberg HD, editors. Clinical Microbiology Procedures Handbook. 2th ed. Washington, (DC): ASM press; 2004. p.3.18.2.1-21.
11. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 7th ed. M7-A7, Wayne, PA: CLSI; 2006.
12. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38:40-43.
13. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40:3798-3801.
14. Sader HS, Reis AO, Silbert S, Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 2005; 11:73-76.
15. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, et al. Molecular characterization of SPM-1 a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother 2002; 50:673-679.
16. Gales AC, Tognim MCB, Reis AO, Jones RN, Sader HS. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis 2003; 45:77-79.
17. Kaufmann M. Pulsed-field-gel-electrophoresis. In: Woodford N, Johnson AP, editors. Molecular Bacteriology: protocols and clinical applications. New Jersey: Human Press; 1988. p. 33-51.
18. Parkins MD, Pitout JD, Church DL, Conly JM, Laupland KB. Treatment of infections caused by metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region. Clin Microbiol Infect 2007;13:199-202.
19. Corvec S, Poirel L, Espaze E, Giraudeau C, Drugeon H, Nordmann P. Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J Hosp Infect 2008; 68:73-82.
20. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18:306-325.
21. Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 2007; 51:3531-3536.
22. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemoter 2006; 50:1633-1641.
23. Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother 2007; 60:132-135.
24. Hancock RE. Resistence mechanisms in Pseudomonas aeruginosa and other non fermentative gram-negative bacteria. Clin Infect Dis 1998; 27:93-99.
25. Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, et al. Metallo-β-Lactamase Detection: Comparative Evaluation of Double-Disk Synergy versus Combined Disk Tests for IMP, GIM, SIM, SPM or VIM-producing isolates. J Clin Microbiol 2008; 46:2028-2037.
26. Mendes RE, Toleman MA, Ribeiro J, Sader HS, Jones RN, Walsh TR. Integron carrying a novel metallo-β-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2004; 48:4693-4702.
27. Pellegrino FL, Casali N, Dos Santos KR, Nouer SA, Scheidegger EM, Riley LW, et al. Pseudomonas aeruginosa epidemic strain carrying bla(SPM) metallo-β-lactamase detected in Rio de Janeiro. Brazil. J Chemother 2006; 18:151-156.
28. Poirel L, Magalhaes M, Lopes M, Nordmann P. Molecular analysis of metallo-β-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother 2004; 48:1406-1409.
29. Cipriano R, Vieira VV, Fonseca EL, Rangel K, Freitas FS, Vicente AC. Coexistence of epidemic colistin-only-sensitive clones of Pseudomonas aeruginosa, including the blaSPM clone, spread in hospitals in a Brazilian Amazon City. Microb Drug Resist 2007; 13:142-146.
30. Carvalho AP, Albano RM, de Oliveira DN, Cidade DA, Teixeira LM, Marques-Ede A. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a hospital located in Rio de Janeiro, Brazil. Microb Drug Resist 2006; 12:103-108.